These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 27137706)
1. Association of CYP2C19 Polymorphisms with the Clinical Efficacy of Clopidogrel Therapy in Patients Undergoing Carotid Artery Stenting in Asia. Zhu WY; Zhao T; Xiong XY; Li J; Wang L; Zhou Y; Gong ZL; Cheng SY; Liu Y; Shuai J; Yang QW Sci Rep; 2016 May; 6():25478. PubMed ID: 27137706 [TBL] [Abstract][Full Text] [Related]
2. Patients carrying CYP2C19 loss of function alleles have a reduced response to clopidogrel therapy and a greater risk of in-stent restenosis after endovascular treatment of lower extremity peripheral arterial disease. Guo B; Tan Q; Guo D; Shi Z; Zhang C; Guo W J Vasc Surg; 2014 Oct; 60(4):993-1001. PubMed ID: 24877854 [TBL] [Abstract][Full Text] [Related]
3. Influence of CYP2C19 polymorphisms on platelet reactivity and clinical outcomes in ischemic stroke patients treated with clopidogrel. Qiu LN; Sun Y; Wang L; Han RF; Xia XS; Liu J; Li X Eur J Pharmacol; 2015 Jan; 747():29-35. PubMed ID: 25489921 [TBL] [Abstract][Full Text] [Related]
4. Influence of Genetic Polymorphisms on Clopidogrel Response and Clinical Outcomes in Patients with Acute Ischemic Stroke CYP2C19 Genotype on Clopidogrel Response. Han Y; Lv HH; Liu X; Dong Q; Yang XL; Li SX; Wu S; Jiang JM; Luo Z; Zhu DS; Zhang Y; Zheng Y; Guan YT; Xu JF CNS Neurosci Ther; 2015 Sep; 21(9):692-7. PubMed ID: 26177117 [TBL] [Abstract][Full Text] [Related]
5. Effect of CYP2C19*2 and *3 on clinical outcome in ischemic stroke patients treated with clopidogrel. Wang Y; Cai H; Zhou G; Zhang Z; Liu X J Neurol Sci; 2016 Oct; 369():216-219. PubMed ID: 27653892 [TBL] [Abstract][Full Text] [Related]
6. Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles. Lin J; Han Z; Wang C; Yi X; Chai Z; Zhou Q; Huang R Eur J Clin Pharmacol; 2018 Sep; 74(9):1131-1140. PubMed ID: 29804161 [TBL] [Abstract][Full Text] [Related]
7. Concomitant Use of Proton Pump Inhibitors and Clopidogrel Is Not Associated with Adverse Outcomes after Ischemic Stroke in Chinese Population. Yi X; Zhou Q; Wang C; Lin J; Cheng W; Chi L J Stroke Cerebrovasc Dis; 2016 Dec; 25(12):2859-2867. PubMed ID: 27546731 [TBL] [Abstract][Full Text] [Related]
8. Variant recurrent risk among stroke patients with different CYP2C19 phenotypes and treated with clopidogrel. Sun W; Li Y; Li J; Zhang Z; Zhu W; Liu W; Cai Q; Wang X; Cao L; Bai W; Fan X; Ma M; Guo R; Liu X; Xu G Platelets; 2015; 26(6):558-62. PubMed ID: 25207801 [TBL] [Abstract][Full Text] [Related]
9. CYP2C19 and CES1 polymorphisms and efficacy of clopidogrel and aspirin dual antiplatelet therapy in patients with symptomatic intracranial atherosclerotic disease. Hoh BL; Gong Y; McDonough CW; Waters MF; Royster AJ; Sheehan TO; Burkley B; Langaee TY; Mocco J; Zuckerman SL; Mummareddy N; Stephens ML; Ingram C; Shaffer CM; Denny JC; Brilliant MH; Kitchner TE; Linneman JG; Roden DM; Johnson JA J Neurosurg; 2016 Jun; 124(6):1746-51. PubMed ID: 26587656 [TBL] [Abstract][Full Text] [Related]
10. Association Between CYP2C19 Loss-of-Function Allele Status and Efficacy of Clopidogrel for Risk Reduction Among Patients With Minor Stroke or Transient Ischemic Attack. Wang Y; Zhao X; Lin J; Li H; Johnston SC; Lin Y; Pan Y; Liu L; Wang D; Wang C; Meng X; Xu J; Wang Y; JAMA; 2016 Jul; 316(1):70-8. PubMed ID: 27348249 [TBL] [Abstract][Full Text] [Related]
11. Effect of CYP2C19 Polymorphisms on the Platelet Response to Clopidogrel and Influence on the Effect of High Versus Standard Dose Clopidogrel in Carotid Artery Stenting. González A; Moniche F; Cayuela A; García-Lozano JR; Torrecillas F; Escudero-Martínez I; Gonzalez-Marcos JR; Mayol A; Montaner J Eur J Vasc Endovasc Surg; 2016 Feb; 51(2):175-86. PubMed ID: 26526111 [TBL] [Abstract][Full Text] [Related]
12. Effect of CYP2C19*2 and *3 loss-of-function alleles on platelet reactivity and adverse clinical events in East Asian acute myocardial infarction survivors treated with clopidogrel and aspirin. Jeong YH; Tantry US; Kim IS; Koh JS; Kwon TJ; Park Y; Hwang SJ; Bliden KP; Kwak CH; Hwang JY; Gurbel PA Circ Cardiovasc Interv; 2011 Dec; 4(6):585-94. PubMed ID: 22045970 [TBL] [Abstract][Full Text] [Related]
13. CYP2C19 polymorphisms and antiplatelet effects of clopidogrel in acute ischemic stroke in China. Jia DM; Chen ZB; Zhang MJ; Yang WJ; Jin JL; Xia YQ; Zhang CL; Shao Y; Chen C; Xu Y Stroke; 2013 Jun; 44(6):1717-9. PubMed ID: 23640828 [TBL] [Abstract][Full Text] [Related]
14. Aspirin plus clopidogrel may reduce the risk of early neurologic deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles. Yi X; Zhou Q; Wang C; Lin J; Chai Z J Neurol; 2018 Oct; 265(10):2396-2403. PubMed ID: 30128710 [TBL] [Abstract][Full Text] [Related]
15. Potential Usefulness of Clopidogrel Pharmacogenetics in Cerebral Endovascular Procedures and Carotid Artery Stenting. Duconge J; Hernandez-Suarez DF Curr Clin Pharmacol; 2017; 12(1):11-17. PubMed ID: 28245774 [TBL] [Abstract][Full Text] [Related]
16. [Association of CYP2C19 gene polymorphisms with long-term recurrent risk of ischemic stroke among ethnic Han Chinese from Fujian]. Fang L; Zhao Y; Wang N; Yang Z; Huang H; Lin M Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Dec; 32(6):871-6. PubMed ID: 26663068 [TBL] [Abstract][Full Text] [Related]
17. CYP2C19 polymorphisms and clopidogrel efficacy in the secondary prevention of ischemic stroke: a retrospective observational study. Lin J; Mo Y; Cai D; Mao D; Fu H; Wei D Ann Palliat Med; 2021 Dec; 10(12):12171-12180. PubMed ID: 35016407 [TBL] [Abstract][Full Text] [Related]
18. Association between platelet function and recurrent ischemic vascular events after TIA and minor stroke . Zhang J; Zhang J; Sun H; Ming T; Liu X; Cong Y; Li F; Li Z Int J Clin Pharmacol Ther; 2017 Oct; 55(10):789-797. PubMed ID: 28766499 [TBL] [Abstract][Full Text] [Related]
19. Impact of CYP2C19 Polymorphisms on Clinical Outcomes and Antiplatelet Potency of Clopidogrel in Caucasian Poststroke Survivors. Tomek A; Matʼoška V; Frýdmanová A; Magerová H; Šrámek M; Paulasova-Schwabová J; Růžičková T; Janský P; Šarbochová I; Hadačová I; Kaplan V; Lacinová Z; Táborský L; Serebruany V Am J Ther; 2018; 25(2):e202-e212. PubMed ID: 29509167 [TBL] [Abstract][Full Text] [Related]
20. Concomitant Use of Proton-Pump Inhibitors and Clopidogrel Increases the Risk of Adverse Outcomes in Patients With Ischemic Stroke Carrying Reduced-Function CYP2C19*2. Yi X; Han Z; Zhou Q; Cheng W; Lin J; Wang C Clin Appl Thromb Hemost; 2018 Jan; 24(1):55-62. PubMed ID: 27637911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]